BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ronchetti S, Gentili M, Ricci E, Migliorati G, Riccardi C. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:1017-25. [PMID: 31961437 DOI: 10.1093/ibd/izz331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Alvarez X, Sestak K, Byrareddy SN, Mohan M. Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques. Viruses 2020;12:E713. [PMID: 32630206 DOI: 10.3390/v12070713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Gentili M, Hidalgo-Garcia L, Vezza T, Ricci E, Migliorati G, Rodriguez-Nogales A, Riccardi C, Galvez J, Ronchetti S. A recombinant glucocorticoid-induced leucine zipper protein ameliorates symptoms of dextran sulfate sodium-induced colitis by improving intestinal permeability. FASEB J 2021;35:e21950. [PMID: 34613638 DOI: 10.1096/fj.202100778RRRR] [Reference Citation Analysis]
3 Ricci E, Roselletti E, Gentili M, Sabbatini S, Perito S, Riccardi C, Migliorati G, Monari C, Ronchetti S. Glucocorticoid-Induced Leucine Zipper-Mediated TLR2 Downregulation Accounts for Reduced Neutrophil Activity Following Acute DEX Treatment. Cells 2021;10:2228. [PMID: 34571877 DOI: 10.3390/cells10092228] [Reference Citation Analysis]
4 Ronchetti S, Ayroldi E, Ricci E, Gentili M, Migliorati G, Riccardi C. A Glance at the Use of Glucocorticoids in Rare Inflammatory and Autoimmune Diseases: Still an Indispensable Pharmacological Tool? Front Immunol 2020;11:613435. [PMID: 33584696 DOI: 10.3389/fimmu.2020.613435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Parayath NN, Hao S, Stephan SB, Koehne AL, Watson CE, Stephan MT. Genetic in situ engineering of myeloid regulatory cells controls inflammation in autoimmunity. J Control Release 2021:S0168-3659(21)00446-6. [PMID: 34437913 DOI: 10.1016/j.jconrel.2021.08.040] [Reference Citation Analysis]
6 Lucafò M, Bramuzzo M, Selvestrel D, Da Lozzo P, Decorti G, Stocco G. Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease. Front Immunol 2021;12:673068. [PMID: 34054855 DOI: 10.3389/fimmu.2021.673068] [Reference Citation Analysis]